Zimmer Biomet acquires Monogram Technologies for $177M to add autonomous surgical robots

Zimmer Biomet Holdings, Inc./ROSA Robotics

Zimmer Biomet agreed to acquire Israeli-founded Monogram Technologies for $177 million in upfront payments plus up to $12.37 per share in contingent value rights tied to product, regulatory and revenue milestones through 2030. Monogram's semi-autonomous and fully autonomous orthopedic surgical robots will be integrated into the ROSA platform.

• Monogram has developed semi-autonomous and fully autonomous total knee and hip arthroplasty robots
• Semi-autonomous system received FDA 510(k) clearance in March 2025
• Semi-autonomous ROSA variant launching early 2027; fully autonomous variant in late 2027 or early 2028
• Combined offering positions Zimmer as first and only company offering fully autonomous orthopedic surgical robots